Understanding Shared Clinical & Molecular Features Across IPF and Autoimmune-Related ILD
- Exploring overlap in clinical presentation, progression patterns, and outcomes across IPF and CTD-ILD
- What emerging molecular and biomarker insights reveal about shared and distinct disease mechanisms in fibrotic ILDs
- Implications for diagnosis, patient stratification, and therapeutic development across heterogeneous ILD populations